Healthcare - Biotechnology - NASDAQ - US
$ 24.41
-2.05 %
$ 1.19 B
Market Cap
-13.05
P/E
Price Target
Average
48.50%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--9.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Enliven Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ELVN of $36.2 , with forecasts ranging from a low of $32 to a high of $40 .
ELVN Lowest Price Target
Wall Street Target
32 USD
31.09%
ELVN Average Price Target
Wall Street Target
36.2 USD
48.50%
ELVN Highest Price Target
Wall Street Target
40 USD
63.87%
REVENUE FORECAST
Revenue Forecast Chart ELVN
EBIT FORECAST
EBIT Forecast Chart ELVN
NET INCOME FORECAST
Net Income Chart ELVN